Retevmo price in India | Indian Pharma Network
-
Retevmo: Availability in India
The medicine Retevmo contains the active ingredient Selpercatinib, a kinase inhibitor that is used in the treatment of advanced or metastatic RET-mutant medullary thyroid cancer, metastatic RET fusion-positive non-small cell lung cancer, and advanced or metastatic RET fusion-positive thyroid cancer. Selpercatinib is supplied in capsules of 40 mg and 80 mg for oral intake. To know Retevmo price in India or to place an order, call us at 1800-889-1064 or write to us at info@indianpharmanetwork.in.